New York state is receiving tens of millions of dollars in money from the consulting firm McKinsey & Company as part of a broader settlement agreement for the company's role in the opioid crisis. But one lawmaker is worried $20 million of that $32 million settlement won't go toward treating addiction and providing addiction services.

Sen. Peter Harckham, the top Democrat on the chamber's Alcoholism and Substance Committee, in a statement said he's concerned most of the settlement funding is going toward the state's general fund, and won't be used for specific efforts to combat addiction.

“Families and advocates have a right to be outraged by this action,” Harckham said. “This is blood money. Families have a right to know that this settlement is being used in its entirety to incrementally fight the scourge that took the lives of their loved ones. It is obscene to realize that instead of helping to fight our ongoing crisis in opioid overdoses these resources will be used to fill potholes or build walkways to nowhere.”

Freeman Klopott, a spokesman for Gov. Andrew Cuomo's budget office, pointed to $11 million in funding that will be used for addiction treatment in the state prison system. The state's addiction fighting efforts will also be bolstered by millions of dollars from the government.

“New York State has fought hard to ensure those who prospered from the opioid crisis pay a price that offsets the costs of combatting it and all $28 million the state will receive from this settlement in Fiscal Year 2022 is dedicated to combatting addiction and save lives as directed by the legislature in the budget they passed this month, including $11 million to increase support for medication assisted treatment in state prisons, and $1.25 million to restore funding for syringe exchange programs and for the purchase of naloxone to combat overdoses," he said. "Meanwhile, the federal government is adding $105 million to the effort to combat addiction in New York over the next two years.”